Advertisement

When Should We Stop Intravesical Treatment in Patients with Superficial Bladder Cancer?

  • B. von Heyden
  • G. Jakse
Conference paper
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 126)

Abstract

Transurethral resection (TUR) is the treatment of choice for patients with superficial bladder cancer (i.e., Ta, T1 tumors). There are few patients in whom cystectomy is indicated as the initial treatment. External beam irradiation or brachytherapy is applied only in special centers. External beam irradiation certainly does not lower the recurrence rate or improve survival compared to TUR [22]. Interstitial radium implants used in a very selected group of patients seem to be highly effective, both in terms of survival and recurrence rate [26].

Keywords

Transitional Cell Carcinoma Invasive Bladder Cancer Superficial Bladder Cancer Prostatic Urethra Intravesical Chemotherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bretton PR, Herr HW, Badalament RA. The treatment of superficial transitional cell carcinoma of the bladder with mucosal and/or ductal involvement of the prostatic urethra with intravesical BCG. J Urol 141:853–856Google Scholar
  2. 2.
    Bretton PR, Herr HW, Kimrnel M, Whitmore WF, Laudone V, Oettgen HF, Fair WR (1990) The response of patients with superficial bladder cancer to a second course of intravesical BCG. J Urol 143:710PubMedGoogle Scholar
  3. 3.
    Brosman SA (1985) The use of BCG in the therapy of bladder carcinoma in situ. J Urol 134:36PubMedGoogle Scholar
  4. 4.
    Catalona WJ, Hudson MA, Gillen DP, Andriole GL, Ratliff TL (1987) Risks and benefits of repeated courses of intravesical bacillus Calmette-Guérin theapy for superficial bladder cancer. J Urol 137:220PubMedGoogle Scholar
  5. 5.
    Dalessio O, Schulman CC, Sylvester R, dePauw M, Robinson M, Denis L, Smith PH, Viggiano G (1983) Prognostic factors in superficial bladder cancer. J Urol 129:730Google Scholar
  6. 6.
    Fitzpatrick JM, Khan O, Oliver RT, Riddle PR (1979) Longterm follow-up in patients with superficial bladder tumours treated with intravesical Epodyl. Br J Urol 51:545PubMedCrossRefGoogle Scholar
  7. 7.
    Flamm J, Havelec L (1990) Factors affecting survival in primary superficial bladder cancer. Eur Urol 17:113PubMedGoogle Scholar
  8. 8.
    Fossa SD (1985) The need for long term follow-up studies after treatment of superficial bladder cancer, especially after intravesical chemotherapy. In: EORTC Genitiurinary Group monograph 2, part B: superficial bladder tumors. Liss, New York, pp 31–37Google Scholar
  9. 9.
    Green DF, Robinson MRG, Glashan R, Newling D, Dalesio O, Smith PH (1984) Does intravesical chemotherapy prevent invasive bladder cancer? J Urol 131:33PubMedGoogle Scholar
  10. 10.
    Heney N, Ahmed S, Flanagan MJ, Frable J, Corder M, Hafermann M, Hawkins I (1983) Superficial bladder cancer: progression and recurrence. J Urol 130:1083PubMedGoogle Scholar
  11. 11.
    Herr HW, Badalament RA, Amato DA (1989) Superficial bladder cancer treated with BCG: multivariate analysis of factors affecting tumor progression. J Urol 141:22PubMedGoogle Scholar
  12. 12.
    Herr H, Jakse G, Sheinfeld J (1991) The Tl bladder tumor. J Urol (submitted)Google Scholar
  13. 13.
    Herr H, Pinsky CM, Whitmore WF (1986) Long-term effect of intravesical bacillus Calmette Guérin on flat carcinoma in situ. J Urol 135:265PubMedGoogle Scholar
  14. 14.
    Jakse G, Loidl W, Seeber G, Hofstädter F (1984) Stage Tl, grade 3 transitional cell carcinoma of the bladder; an unfavorable tumor. J Urol 137:39Google Scholar
  15. 15.
    Jakse G (1987) Die Stellung der Zystektomie in der Behandlung des in situ Karzinoms der Harnblase. Akt Urol 18:255CrossRefGoogle Scholar
  16. 16.
    Kavoussi LR, Torrence RJ, Gillen GP, Hudson MA, Haaff EO, Dresner SM, Ratliff TL, Catalona WJ (1988) Results of 6 weekly intravesical bacillus Calmette-Guérin instillations on the treatment of superficial bladder tumors. J Urol 139:935PubMedGoogle Scholar
  17. 17.
    Koontz W Jr, Heney NM, Soloway MS, Platz C, Hazra TA, Trump DL (1985) Mitomycin C for patients who have failed on thio-tepa. Urology 26 [Suppl 4]: 30–31PubMedGoogle Scholar
  18. 18.
    Kurth K-H, Schroeder FH, Debruyne F, Senge T, Pavone-Macaluso M, de Pauw M, ten Kate F, Sylvester R (1989) Long-term follow-up in superficial transitional cell carcinoma of the bladder: prognostic factors for time to first recurrence, recurrence rate and survival. In: Murphy GP, Khoury S (eds) Therapeutic progress in urological cancer. Liss, New York, pp 481–490Google Scholar
  19. 19.
    Kurth K-H, Sylvester R, dePauw M, tenKate F (1989) Intracavitary treatment of transitional cell carcinoma of the bladder: questions and lessons after 27 years of experience. Prog Clin Biol Res 310:40Google Scholar
  20. 20.
    Lutzeyer W. Rübben H, Dahm H (1982) Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 127:250PubMedGoogle Scholar
  21. 21.
    Pagano F, Bassi P, Milam C (1989) Low-dose BCG-Pasteur strain in the treatment of superficial bladder cancer: preliminary results. Prog Clin Biol Res 310:253PubMedGoogle Scholar
  22. 22.
    Quilty PM, Duncan W (1986) Treatment of superficial tumor of the bladder by radical radiotherapy. Br J Urol 58:147PubMedCrossRefGoogle Scholar
  23. 23.
    Rübben H, Lutzeyer W, Fischer N, Deutz F, Lagrange W, Giani G (1988) Natural history and treatment of low and high risk superficial bladder tumors. J Urol 139:283PubMedGoogle Scholar
  24. 24.
    Soloway MS (1988) The management of superficial bladder cancer, with emphasis on intravesical chemotherapy. In: Raghavan D (ed) The management of bladder cancer. Arnold, LondonGoogle Scholar
  25. 25.
    Soloway MS, Ferry A (1987) BCG for treatment of superficial transitional cell carcinoma of the bladder in patients who have failed thiotepa and/or mitomycin C J Urol 137:871Google Scholar
  26. 26.
    van der Werft-Messing B, Hop WCJ (1981) Carcinoma of the urinary bladder treated either by radium implant or by transurethral resection only. Int J Radiat Oncol Biol Phys 7:299CrossRefGoogle Scholar
  27. 27.
    Wolf H, Hojgard K (1983) Prognostic factors in local surgical treatment of invasive bladder cancer with special reference to the presence of urothelial dysplasia. Cancer 51:1710PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • B. von Heyden
    • 1
  • G. Jakse
    • 1
  1. 1.Urologische KlinikRWTH AachenAachenGermany

Personalised recommendations